Is Curia India Private Limited FDA approved?

Curia India Private Limited holds 9 FDA-registered establishments across 5 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Curia India Private Limited's drugs manufactured?

At registered sites in Spain, France, India, Italy, the United States. The FDA register lists BOECILLO; Bon Encontre; Tonneins; Aurangabad; Origgio; ROZZANO, and 3 more. Registered operations: analytical testing, active ingredient (API) manufacture, particle size reduction.

What drugs does Curia India Private Limited make?

106 products are listed under Curia India Private Limited in the openFDA NDC Directory, most often as powder; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Curia India Private Limited

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 9
Active NDC listings: 106
Labeller names: 9
Live patents: 0
Countries: 5
Base: Italy

Authorisation

Registered operations

Analytical testing9Active ingredient (API) manufacture9particle size reduction2

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
CURIA SPAIN SAURegistrant: Curia Spain SAU	LUGAR PARQUE TECNOLOGICO DE BOECILLO PARC 105, BOECILLO, Valladolid 47151, Spain (ESP)	Analytical testing, Active ingredient (API) manufacture, particle size reduction	3002996872563371111
Curia France SASRegistrant: Curia France S.A.S	ZI de Laville, Bon Encontre, 47240, France (FRA)	Analytical testing, Active ingredient (API) manufacture	3009615607288594489
Curia France SASRegistrant: Curia France S.A.S	AVENUE NICOLE BRU RUE JEAN TOURNIE, Tonneins, 47400, France (FRA)	Analytical testing, Active ingredient (API) manufacture	3006257961264285091
Curia India Private Limited	Plot No. G-1/1, 1/2, Near MIDC Water Tank MIDC Area, Waluj, Aurangabad, Maharashtra 431136, India (IND)	Analytical testing, Active ingredient (API) manufacture	3008580576677602796
Curia Italy S.r.l.	Viale Europa 5, Origgio, Varese 21040, Italy (ITA)	Analytical testing, Active ingredient (API) manufacture	1000330416440365766
Curia Italy S.r.l.	VIA MONTEROSA 114 116, ROZZANO, - 20089, Italy (ITA)	Analytical testing, Active ingredient (API) manufacture	3004999657440365768
Curia Italy S.r.l.	Via Volturno 41/43, Rozzano, 20089, Italy (ITA)	Analytical testing, Active ingredient (API) manufacture	3002807919440365767
Curia Global, Inc.Registrant: Curia Global Inc.	21 Corporate Cir, Albany, New York (NY) 12203, United States (USA)	Analytical testing, Active ingredient (API) manufacture	1000220178080046430
Curia New York, Inc.Registrant: Curia Global Inc.	33 Riverside Avenue, Rensselaer, New York (NY) 12144, United States (USA)	Analytical testing, Active ingredient (API) manufacture, particle size reduction	1310298124193793

Catalogue

Drug listings by form and route

106

106 active NDC listings: 106 bulk ingredient. By marketing category: BULK INGREDIENT 71, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 35.

Dosage form	NDCs
powder	105
liquid	1

Route	NDCs

Labeller name on the listing	NDCs
curia italy s.r.l.	44
curia spain s.a.u.	39
curia spain, s.a.u.	10
curia spain s.a.u	5
curia spain sau	3
curia italy s.r.l.	2
curia india private limited	1
curia italy s.r.l	1
curia italy s.r.l	1

Catalogue

Marketed products

106

Brand	Generic name	Form / route	NDC
-	ALTRENOGEST	powder	65089-0048BULK INGREDIENT
-	ARGATROBAN	powder	55486-1582BULK INGREDIENT
-	ATRACURIUM BESYLATE	powder	55486-1597BULK INGREDIENT
-	AZELASTINE HYDROCHLORIDE	powder	55486-1575BULK INGREDIENT
-	Abiraterone acetate	powder	65089-0051BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Aceclidine HCl	powder	55486-1608BULK INGREDIENT
-	Alcaftadine	powder	65089-0063BULK INGREDIENT
-	Alclometasone dipropionate	powder	65089-0012BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Argatroban Monohydrate	powder	55486-1607BULK INGREDIENT
-	Artesunate	powder	65089-0057BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	BROMOCRIPTINE MESYLATE	powder	55486-1561BULK INGREDIENT
-	Beclomethasone dipropionate	powder	65089-0010BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Betamethasone Acetate	powder	65089-0006BULK INGREDIENT
-	Betamethasone dipropionate	powder	65089-0009BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Betamethasone sodium phosphate	powder	65089-0004BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Betamethasone valerate	powder	65089-0031BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Brexanolone	powder	65089-0060BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Budesonide	powder	65089-0005BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Budesonide	powder	65089-0024BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	CHLORTHALIDONE	powder	44657-0034BULK INGREDIENT
-	CHLORTHALIDONE	powder	44657-0058BULK INGREDIENT
-	CITALOPRAM HYDROBROMIDE	powder	55486-1572BULK INGREDIENT
-	CITALOPRAM HYDROCHLORIDE	powder	55486-1598BULK INGREDIENT
-	CYCLOSPORINE	powder	55486-1567BULK INGREDIENT
-	CYCLOSPORINE	powder	55486-1602BULK INGREDIENT
-	CYCLOSPORINE	powder	55486-1603BULK INGREDIENT
-	Chlorthalidone	powder	44657-0057BULK INGREDIENT
-	Clobetasol propionate micronized	powder	65089-0003BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Cyclosporine	powder	55486-1604BULK INGREDIENT
-	DEXAMETHASONE	powder	65089-0045BULK INGREDIENT
-	DIHYDROERGOTAMINE MESYLATE	powder	55486-1587BULK INGREDIENT
-	DIHYDROERGOTAMINE MESYLATE	powder	55486-1599BULK INGREDIENT
-	DONEPEZIL HYDROCHLORIDE	powder	55486-1590BULK INGREDIENT
-	Desogestrel	powder	55486-1569BULK INGREDIENT
-	Desoxycholic acid	powder	65089-0054BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Dexamethasone dipropionate	powder	65089-0065BULK INGREDIENT
-	Dexamethasone isonicotinate	powder	65089-0066BULK INGREDIENT
-	Dexamethasone sodium phosphate	powder	65089-0001BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Dorzolamide Hydrochloride	powder	65089-0039BULK INGREDIENT
-	ERGOLOID MESYLATES	powder	55486-1574BULK INGREDIENT
-	ERGOTAMINE TARTRATE	powder	55486-1581BULK INGREDIENT
-	EXEMESTANE	powder	65089-0046BULK INGREDIENT
-	Ethinyl Estradiol	powder	65089-0044BULK INGREDIENT
-	Etonogestrel	powder	65089-0053BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	FLUTAMIDE	powder	44657-0048BULK INGREDIENT
-	FLUTAMIDE	powder	44657-0056BULK INGREDIENT
-	Fludrocortisone acetate	powder	65089-0015BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Fluoxymesterone	powder	65089-0052BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Fluticasone propionate	powder	65089-0033BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Furosemide	powder	70193-0002BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Hydrocortisone Aceponate	powder	65089-0061BULK INGREDIENT
-	Hydrocortisone Butyrate	powder	65089-0035BULK INGREDIENT
-	Levocabastine Hydrochloride	powder	65089-0042BULK INGREDIENT
-	Levonorgestrel	powder	65089-0036BULK INGREDIENT
-	Loteprednol Etabonate	powder	65089-0037BULK INGREDIENT
-	MECAMYLAMINE HYDROCHLORIDE	powder	55486-1563BULK INGREDIENT
-	METHYLPREDNISOLONE SODIUM SULEPTANATE	powder	65089-0062BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Mecamylamine Base	liquid	55486-1564BULK INGREDIENT
-	Medroxyprogesterone acetate	powder	65089-0002BULK INGREDIENT
-	Medroxyprogesterone acetate	powder	65089-0022BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Methylprednisolone acetate	powder	65089-0016BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Methylprednisolone acetate sterile	powder	65089-0017BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Mifepristone	powder	65089-0043BULK INGREDIENT
-	Minocycline Hydrochloride	powder	44657-0051BULK INGREDIENT
-	Minocycline Hydrochloride	powder	44657-0081BULK INGREDIENT
-	Mometasone Furoate	powder	65089-0025BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Monomethyl Fumarate	powder	44657-0082BULK INGREDIENT
-	NYPRG-101	powder	55486-1605BULK INGREDIENT
-	Nikkomycin Z	powder	65089-0058BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	OXANDROLONE	powder	55486-1570BULK INGREDIENT
-	Obeticholic acid	powder	65089-0055BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Olopatadine Hydrochloride	powder	65089-0041BULK INGREDIENT
-	PALIPERIDONE PALMITATE	powder	65089-0047BULK INGREDIENT
-	PANCURONIUM BROMIDE	powder	55486-1568BULK INGREDIENT
-	PIMECROLIMUS	powder	55486-1585BULK INGREDIENT
-	PROPOFOL	powder	44657-0044BULK INGREDIENT
-	Pancuronio Bromuro	powder	55486-1609BULK INGREDIENT
-	Pramipexole Dihydrochloride	powder	65089-0040BULK INGREDIENT
-	Prednicarbate	powder	65089-0032BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Prednisolone	powder	65089-0038BULK INGREDIENT
-	Prednisolone sodium phosphate	powder	65089-0007BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Prednisone Anhydrous	powder	65089-0030BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	RIBAVIRIN	powder	44657-0076BULK INGREDIENT
-	ROCURONIUM BROMIDE	powder	55486-1593BULK INGREDIENT
-	Rocuronium bromide	powder	55486-1606BULK INGREDIENT
-	Rocuronium bromide	powder	65089-0018BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	SIROLIMUS	powder	55486-1571BULK INGREDIENT
-	Sarecycline Hydrochloride	powder	44657-0079BULK INGREDIENT
-	Segesterone acetate	powder	65089-0019BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Sirolimus Complex	powder	55486-1592BULK INGREDIENT
-	Sodium Mycophenolate	powder	55486-1591BULK INGREDIENT
-	TACROLIMUS	powder	55486-1576BULK INGREDIENT
-	TICLOPIDINE HYDROCHLORIDE	powder	55486-1565BULK INGREDIENT
-	TIGECYCLINE	powder	44657-0055BULK INGREDIENT
-	Testosterone	powder	65089-0068BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Testosterone Cypionate	powder	65089-0049BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Triamcinolone acetonide	powder	65089-0008BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Triamcinolone acetonide crystallized sterile	powder	65089-0023BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-	Upadacitinib	powder	65089-0067BULK INGREDIENT
-	VECURONIUM BROMIDE	powder	55486-1566BULK INGREDIENT
-	Viloxacine Hydrochloride	powder	65089-0064BULK INGREDIENT
-	aztreonam	powder	13538-001BULK INGREDIENT
-	aztreonam	powder	13538-008BULK INGREDIENT
-	aztreonam	powder	13538-009BULK INGREDIENT
-	hydrocortisone base	powder	65089-0059BULK INGREDIENT
-	hydrocortisone sodium phosphate	powder	65089-0056BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING

Neighbours

Registered in the same town

WOCKHARDT LIMITEDAurangabad, IND · 2 sites
PETNET Solutions, Inc.ALBANY, NY
ACUTE CARE GAS LLCAlbany, NY
Gland Chemicals Private LimitedAurangabad, IND
Regeneron Pharmaceuticals, Inc.Rensselaer, NY
Trifarma S.p.A.Rozzano, ITA
MIDAS CARE PHARMACEUTICALS PRIVATE LIMITEDAurangabad, IND

Compare

Comparable companies in Italy

ACS Dobfar S.p.A.8 sites · 37 NDC
Olon USA LLC11 sites · 185 NDC
BRACCO DIAGNOSTICS INC6 sites · 31 NDC
Dipharma Francis Srl4 sites · 72 NDC
Flamma USA LLC4 sites · 13 NDC
Advanced Accelerator Applications USA, Inc.4 sites · 2 NDC
SICOR Societa' Italiana Corticosteroidi s.r.l. ABBREVIATA IN SICOR S.R.L.4 sites · 0 NDC
FIS FABBRICA ITALIANA SINTETICI SPA3 sites · 128 NDC
Kedrion Biopharma Inc.3 sites · 28 NDC
Fresenius Kabi iPSUM S.r.l.3 sites · 24 NDC

Enquiry

Common questions

Is Curia India Private Limited FDA approved?: Curia India Private Limited holds 9 FDA-registered establishments across 5 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Curia India Private Limited's drugs manufactured?: At registered sites in Spain, France, India, Italy, the United States. The FDA register lists BOECILLO; Bon Encontre; Tonneins; Aurangabad; Origgio; ROZZANO, and 3 more. Registered operations: analytical testing, active ingredient (API) manufacture, particle size reduction.
What drugs does Curia India Private Limited make?: 106 products are listed under Curia India Private Limited in the openFDA NDC Directory, most often as powder; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.